Mechanism of anti-proliferation effects of dehydroepiandrosterone on colon cancer
脱氢表雄酮抗结肠癌增殖作用机制
基本信息
- 批准号:10470130
- 负责人:
- 金额:$ 4.03万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Dehydroepiandrosterone (DHEA) is a naturally occurring steroid synthesized in the adrenal, brain and gastrointestinal tract. In vivo and in vitro administration of DHEA inhibits cancer proliferation. Two hypotheses have been proposed so far, 1) depletion of intracellular ribose due to inhibition of glucose-6-phosphate dehydrogenase (G6PD) activity ; and 2) inhibition of p21ras signal transduction pathway by dawn-regulation of HMG-CoA reductase (HMGR). To clarify the mechanism, the effects of DHEA and related steroids on the enzyme activities were studied in HepG2 cells. Cell growth was evaluated by MTT and bromodeoxyuridine incorporation assays. G6PD activity was measured by spectrophotometric assay, and the activities of HMGR and MAP kinase (MAPK), the final enzyme in the p21ras pathway, were determined by radioisotope incorporation methods. All steroids we tested had inhibitory effects on cell growth. Growth inhibition due to pregnenolone (PGN) and epiandrosterone (EA) was greater th … More an that caused by DHEA, while DHEA-sulfate, 7α-OH DHEA, 7β-OH DHEA and 7-keto DHEA had less inhibitory effects than DHEA.There was no significant correlation between growth inhibition and suppression of G6PD (r=0.552, NS) or HMGR (r=0.498, NS) activities. In contrast, highly significant positive correlation was observed between growth inhibition and suppression of MAPK activity (r=0.905, P<0.01).The same results were obtained when growth inhibition was evaluated by MTT assay. There was no significant correlation between inhibition of MTT assay and inhibition of G6PD activity (r=0.566, n=7, P=0.186) or inhibition of HMG-CoA reductase activity (r=0.442, n=7, P=0.321).In contrast, inhibition of MTT assay and inhibition of MAP-kinase was correlated significantly (r=0.807, n=7, P<0.05). These results demonstrate that not only DHEA but also all other steroids examined in this study have anti-proliferation effects on HepG2 cells. Inhibition of MAPK or some upstream molecules in the signal transduction appears to be more responsible for the anti-proliferation effects of these steroids than inhibition of G6PD or HMGR activity. Less
脱氢表雄酮(DHEA)是一种在肾上腺、大脑和胃肠道中合成的天然类固醇。体内和体外给药脱氢表雄酮抑制肿瘤增殖。目前提出了两种假说:1)由于抑制葡萄糖-6-磷酸脱氢酶(G6PD)活性导致细胞内核糖的耗竭;2)通过调控HMG-CoA还原酶(HMGR)抑制p21ras信号转导通路。为了阐明其作用机制,我们在HepG2细胞中研究了脱氢表雄酮和相关类固醇对酶活性的影响。采用MTT法和溴脱氧尿苷掺入法测定细胞生长情况。用分光光度法测定G6PD活性,用放射性同位素掺入法测定HMGR和MAP激酶(MAPK)活性,MAPK是p21ras途径的最终酶。我们测试的所有类固醇都对细胞生长有抑制作用。孕烯醇酮(PGN)和表雄酮(EA)对脱氢表雄酮(DHEA)的抑制作用大于脱氢表雄酮(DHEA),而硫酸脱氢表雄酮、7α-OH脱氢表雄酮、7- β- oh脱氢表雄酮对脱氢表雄酮的抑制作用小于脱氢表雄酮(DHEA)。生长抑制与G6PD (r=0.552, NS)和HMGR (r=0.498, NS)活性无显著相关。相反,生长抑制与MAPK活性抑制呈极显著正相关(r=0.905, P<0.01)。用MTT法评价生长抑制作用,得到了相同的结果。抑制MTT检测与抑制G6PD活性(r=0.566, n=7, P=0.186)或抑制HMG-CoA还原酶活性(r=0.442, n=7, P=0.321)无显著相关性。MTT抑制与map -激酶抑制呈显著相关(r=0.807, n=7, P<0.05)。这些结果表明,除DHEA外,本研究检测的所有其他类固醇均对HepG2细胞具有抗增殖作用。抑制MAPK或信号转导中的一些上游分子似乎比抑制G6PD或HMGR活性更能发挥这些类固醇的抗增殖作用。少
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Honda A, Tanaka N et al.: "Regulation q 25-and 27-hydroxyletion side chain cleavage pathways for cholic acid"J Lipid Res. (in press). (2000)
Honda A、Tanaka N 等人:“胆酸的 25-和 27-羟基化侧链裂解途径的调节”J Lipid Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Honda A,Tanaka N et al: "3-Hydroxy-3-methylglutaryl Coenzyme A reductase activity is inherited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts"J Lab Clin Med. 135(2). 174-179 (2000)
Honda A、Tanaka N 等人:“在谷甾醇成纤维细胞中,3-羟基-3-甲基戊二酰辅酶 A 还原酶活性由胆固醇遗传,并由谷甾醇上调”J Lab Clin Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Saito Y,Tanaka N et al: "Multiple regression analysis for assessing the growth of small lepate celluler carcerome" J Gastroenterology. 33(2). 229-235 (1998)
Saito Y、Tanaka N 等人:“用于评估小细胞癌生长的多元回归分析”J Gastroenterology。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Obara M,Tanaka N et al: "Diagnestic procedures in obtaining pathological materials for pulmonary nodules due to primary lung cancey" Oncology Reports. 5. 1237-1239 (1998)
Obara M、Tanaka N 等人:“获取原发性肺癌肺结节病理材料的诊断程序”肿瘤学报告。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
福島清乃,松崎靖司,田中直見: "胆汁酸と大腸癌"臨床医. 26. 1722-1725 (2000)
Kiyono Fukushima、Yasushi Matsuzaki、Naomi Tanaka:“胆汁酸和结直肠癌”临床医生。26. 1722-1725 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Naomi其他文献
TANAKA Naomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Naomi', 18)}}的其他基金
Experimental Analysis and Application of Cancer-selectively Replicating Adenovirus for Gene Therapy of Gallbladder Cancer.
癌症选择性复制腺病毒在胆囊癌基因治疗中的实验分析及应用。
- 批准号:
14370174 - 财政年份:2002
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The immunopathogenesis and the regulation of hepatic lesions in murine model of primary biliary cirrhosis.
原发性胆汁性肝硬化小鼠模型的免疫发病机制及肝脏病变的调控。
- 批准号:
08457160 - 财政年份:1996
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of cholesterol crystallization-promoting protein in the pathogenesis of cholesterol gallstone.
胆固醇结晶促进蛋白在胆固醇胆结石发病机制中的作用。
- 批准号:
05670445 - 财政年份:1993
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Regulation of Vascular Smooth Muscle Cell Phenotype by a Novel Isoform of Glucose-6-Phosphate Dehydrogenase
新型葡萄糖-6-磷酸脱氢酶异构体对血管平滑肌细胞表型的调节
- 批准号:
10561265 - 财政年份:2022
- 资助金额:
$ 4.03万 - 项目类别:
Development of a glucose-6-phosphate dehydrogenase/ haemoglobin point-of-care test for malaria elimination
开发消除疟疾的葡萄糖-6-磷酸脱氢酶/血红蛋白即时检测
- 批准号:
nhmrc : GNT1136027 - 财政年份:2018
- 资助金额:
$ 4.03万 - 项目类别:
Development Grants
Assessing the tolerability of a potentially safer radical curative regimen of primaquine in healthy volunteers with glucose 6 phosphate dehydrogenase
使用葡萄糖 6 磷酸脱氢酶评估健康志愿者对可能更安全的伯氨喹根治方案的耐受性
- 批准号:
MR/R015252/1 - 财政年份:2018
- 资助金额:
$ 4.03万 - 项目类别:
Research Grant
Development of a glucose-6-phosphate dehydrogenase/ haemoglobin point-of-care test for malaria elimination
开发消除疟疾的葡萄糖-6-磷酸脱氢酶/血红蛋白即时检测
- 批准号:
nhmrc : 1136027 - 财政年份:2018
- 资助金额:
$ 4.03万 - 项目类别:
Development Grants
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
PreQuine 平台。
- 批准号:
10681396 - 财政年份:2017
- 资助金额:
$ 4.03万 - 项目类别:
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
PreQuine 平台。
- 批准号:
10324765 - 财政年份:2017
- 资助金额:
$ 4.03万 - 项目类别:
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
PreQuine 平台。
- 批准号:
10470348 - 财政年份:2017
- 资助金额:
$ 4.03万 - 项目类别:
Differential control of glucose-6-phosphate dehydrogenase in a hibernating mammal
冬眠哺乳动物中葡萄糖-6-磷酸脱氢酶的差异控制
- 批准号:
496533-2016 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别:
University Undergraduate Student Research Awards
Assessing the safety of low dose primaquine in Plasmodium falciparum infected African children with glucose 6 phosphate dehydrogenase deficiency.
评估低剂量伯氨喹对感染恶性疟原虫且患有葡萄糖 6 磷酸脱氢酶缺乏症的非洲儿童的安全性。
- 批准号:
MR/P006973/1 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别:
Research Grant
Mechanistic Studies on F420 dependent Glucose-6-Phosphate Dehydrogenase from Mycobacteria tuberculosis
结核分枝杆菌F420依赖性葡萄糖-6-磷酸脱氢酶的机制研究
- 批准号:
9232806 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别: